HEALTH CARE RESOURCE UTILIZATION (HCRU) OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NIVOLUMAB VERSUS DOCETAXEL: RESULTS FROM THE CHECKMATE 078 (CM078) TRIAL

被引：0
作者：
Lawrance, R. [1 ]
DeRosa, M. [2 ]
Taylor, F. [2 ]
Penrod, J. R. [3 ]
Shaw, J. W. [4 ]
Wang, P. F. [5 ]
机构：
[1] Adelphi Values, Bollington SK10 5JB, Cheshire, England
[2] Adelphi Values, Boston, MA USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[5] BMS, Jamison, PR USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.247
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN123
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [31] Multicenter, randomized study of Docetaxel versus Docetaxel plus Oblimersen in patients previously treated for non-small cell lung cancer (NSCLC)
    Herbst, Roy S.
    Ansari, Rafat H.
    Gorbunova, V
    Manikhas, G.
    Mansoor, N. Boyd
    Thomas, E.
    Azzoli, Christopher G.
    Robert, Francisco
    Itri, Loretta M.
    Chapman, Robert
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S335 - S335
  • [32] Hyper-progressive disease in patients with advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo)
    Costantini, Adrien
    Corny, Jennifer
    Fallet, Vincent
    Renet, Sophie
    Friard, Sylvie
    Chouaid, Christos
    Duchemann, Boris
    Giroux-Leprieur, Etienne
    Taillade, Laurent
    Doucet, Ludovic
    Nguenang, Marina
    Jouveshomme, Stephane
    Wislez, Marie
    Tredaniel, Jean
    Cadranel, Jacques
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [33] Cobolimab with Dostarlimab and Docetaxel in Patients with Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, H. R.
    Gridelli, C.
    Kapur, D.
    Tufman, A.
    Felip, E.
    Velcheti, V.
    Kim, Y. J.
    Goetze, T. O.
    Lopez, P. Garrido
    Corre, R.
    Penkov, K.
    Anjum, R.
    Di Pace, B.
    Liu, W.
    Borgovan, T.
    Ledger, D.
    Carver, J.
    Waszak, A.
    Dhar, A.
    Novello, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S109 - S110
  • [34] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] A randomized phase II/ III trial of nivolumab versus nivolumab plus docetaxel for previously treated advanced or recurrent non-small cell lung cancer: TORG1630.
    Kawashima, Yosuke
    Taniguchi, Yuri
    Shimokawa, Tsuneo
    Takiguchi, Yuichi
    Misumi, Toshihiro
    Nakamura, Atsushi
    Furuya, Naoki
    Tanaka, Kentaro
    Harada, Toshiyuki
    Tanaka, Hisashi
    Miura, Satoru
    Sata, Masafumi
    Kato, Terufumi
    Tokito, Takaaki
    Naoki, Katsuhiko
    Bessho, Akihiro
    Goto, Yasuhiro
    Nakamichi, Shinji
    Okamoto, Hiroaki
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Health Resource Utilization in Patients with Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy in China
    Shi, Jing
    Zhu, Jun
    CLINICAL DRUG INVESTIGATION, 2016, 36 (01) : 77 - 86
  • [37] Health Resource Utilization in Patients with Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy in China
    Jing Shi
    Jun Zhu
    Clinical Drug Investigation, 2016, 36 : 77 - 86
  • [38] Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer
    Ramagopalan, Sreeram
    Gupta, Alind
    Arora, Paul
    Thorlund, Kristian
    Ray, Joshua
    Subbiah, Vivek
    JAMA NETWORK OPEN, 2021, 4 (11)
  • [39] Evaluation of Disease-Related Symptoms in Patients with Advanced Squamous Non-Small Cell Lung Cancer Treated with Nivolumab or Docetaxel
    Gralla, Richard J.
    Coon, Cheryl
    Taylor, Fiona
    Penrod, John R.
    Derosa, Michael
    Dastani, Homa
    Orsini, Lucinda
    Reck, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S233 - S234
  • [40] Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)
    Zalcberg, JR
    Bishop, JF
    Millward, MJ
    Zimet, A
    Laird, J
    Barter, C
    Seward, D
    McKeage, MJ
    Friedlander, ML
    Toner, G
    Berille, J
    Blanc, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1084 - 1084
12345